Fox Chase Cancer Center News

PHILADELPHIA (October 19, 2020)—Philadelphia magazine has named 72 Temple and Fox Chase Cancer Center physicians to its “Top Doctors in Cancer Care” list for 2020. Physicians on the list were nominated by their professional peers.

PHILADELPHIA (October 16, 2020)—Fox Chase Cancer Center presented its signature fundraising event, In Vino Vita, on Friday, October 2, 2020. The seventh annual event was held virtually for the first time this year and raised over $700,000 for cancer research at Fox Chase.

PHILADELPHIA (October 14, 2020)—Fox Chase Cancer Center has been selected as the newest institution in The Melanoma Research Foundation Breakthrough Consortium (MRFBC).

PHILADELPHIA (October 12, 2020)— Christian A. Koch, MD, PhD, FACP, MACE, director of endocrinology and researcher in the Department of Medicine at Fox Chase Cancer Center, recently assisted in the publication of a special edition of The Journal of Clinical and Translational Endocrinology that highlighted methods of managing patients with hyperthyroidism.

PHILADELPHIA (October 12, 2020)—Researchers at Fox Chase Cancer Center recently published a case study that proposes that severe low calcium levels known as hypocalcemia may result from an inflammatory reaction with transient hypoparathyroidism after hyperthermic intraperitoneal chemotherapy (HIPEC) treatment.

PHILADELHIA (October 12, 2020) — Colleen Tetzlaff, MHS, PA-C, an advanced practice clinician at Fox Chase Cancer Center, was recently named president of the Association of Physician Assistants in Oncology (APAO) for 2020-2021.

PHILADELPHIA (October 9, 2020)—October is Breast Cancer Awareness Month, and Fox Chase Cancer Center encourages women to schedule a screening mammogram for breast cancer. Screening mammograms can help detect breast cancer early, before any symptoms appear, and when there is better chance for successful treatment.

PHILADELPHIA (October 7, 2020)— Joan Font-Burgada, PhD, assistant professor in the Cancer Biology Research Program at Fox Chase Cancer Center, has received a National Institutes of Health (NIH) Director’s New Innovator Award from the NIH Common Fund’s High-Risk, High-Reward Research program.